bluebird bio Inc (NASDAQ:BLUE)
| 8.09 BATS BZX Real-Time Price As of 1:35pm ET |  +0.33 / +4.25%Today’s Change | 6.75 Today|||52-Week Range 31.67 | -19.02% Year-to-Date |
Latest BLUE News | Press Releases
| Is a Beat in Store for HCA Healthcare's (HCA) Q4 Earnings? Jan 24 / Zacks.com - Paid Partner Content | bluebird (BLUE) Gene Therapies BLA Decision Delayed, Stock Down Jan 19 / Zacks.com - Paid Partner Content |
| Anthem (ANTM) Gears Up for Q4 Earnings: What's in the Cards? Jan 21 / Zacks.com - Paid Partner Content | Why Bluebird Bio Stock Is Sinking This Week Jan 14 / MotleyFool.com - Paid Partner Content |
| Biotech Stock Roundup: ZGNX's Acquisition News, REGN, BLUE's Updates & More Jan 20 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 7.76 |
| Today’s open | 7.91 |
| Day’s range | 7.69 - 8.14 |
| Volume | 42,205 |
| Average volume (3 months) | 2,011,025 |
| Market cap | $509.0M |
Data as of 1:35pm ET, 01/26/2022
Growth & Valuation
| Earnings growth (last year) | +30.45% |
| Earnings growth (this year) | -80.12% |
| Earnings growth (next 5 years) | -64.66% |
| Revenue growth (last year) | +461.25% |
| P/E ratio | NM |
| Price/Sales | 10.73 |
| Price/Book | 0.36 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PSNLPersonalis Inc | +0.87 | +8.39% |
| VXRTVaxart Inc | +0.21 | +4.46% |
| BNGOBionano Genomics Inc | +0.10 | +4.89% |
| DCPHDeciphera Pharmaceut... | +0.26 | +3.07% |
Data as of 1:36pm ET, 01/26/2022
Financials
| Next reporting date | February 23, 2022 |
| EPS forecast (this quarter) | -$1.97 |
| Annual revenue (last year) | $250.7M |
| Annual profit (last year) | -$618.7M |
| Net profit margin | -246.75% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
